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Background: Tuberculous endophthalmitis is very rare with only 18 reports published worldwide and only a few
cases in Japan. We report a case of tuberculous endophthalmitis successfully treated with vitrectomy followed by
antituberculous agents.
Findings: An 81-year-old man was referred to us due to the exacerbation of vitreous opacity on his left eye(OS)
after he had received the corticosteroid therapy. His best corrected visual acuity was light perception OS, and
he had severe intraocular inflammation with fibrin formation in the anterior chamber and dense vitreous opacity.
A chest CT showed miliary nodules indicating miliary tuberculosis, and pars plana vitrectomy was performed.
Intraoperative observation showed that the vitreous cavity was filled by fibrin, and large elevated subretinal
yellow-white lesions were present at the mid-periphery. The patient immediately received triple antituberculous
agents orally, and Mycobacterium tuberculosis was detected in vitreous fluids. The intraocular inflammation gradually
decreased, and the subretinal mass regressed within 2 weeks.
Conclusions: We encountered a case of tuberculous endophthalmitis successfully treated with vitrectomy followed
by antituberculous agents. If endophthalmitis is suspected in a patient with systemic tuberculosis infection, prompt
vitrectomy along with the administration of antituberculous agents may be necessary.
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Introduction
Tuberculosis is a serious infectious disease that has re-
emerged as a public health problem in recent years and
is ranked as an important cause of death worldwide [1].
Intraocular tuberculosis represents an extrapulmonary
form of this disease. Approximately 1% to 2% of patients
with tuberculosis show ocular involvement, in the lids,
conjunctiva, cornea, sclera, uveal tract, optic nerve, or
orbit [2]. The most common form of ocular involvement
is uveitis. In tubercular uveitis, posterior or panuveitis is
the most common type and includes choroidal tuber-
cules, choroidal tuberculoma, subretinal abscess, and
serpiginous-like choroiditis [3]. However, the most* Correspondence: knamba@med.hokudai.ac.jp
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in any medium, provided the original work is pfrequent type in Japan is retinal vasculitis, while the
other types are rare. Moreover, the development from
ocular tuberculosis to endophthalmitis is very rare, and
only a few cases have been reported in Japan [4]. To the
best of our knowledge, only 18 reports have been previ-
ously published worldwide, and almost all of these cases
underwent enucleation or evisceration [1,5,6] because
they rapidly progressed with destruction of the intraocular
tissues. We report a case of tuberculous endophthalmitis
that resulted in the remission of ocular inflammation by
pars plana vitrectomy (PPV) combined with subsequent
administration of antituberculous agents.
Case report
The case was an 81-year-old Japanese man who had visited
an ophthalmology clinic complaining of blurred vision of
the left eye with periocular pain and was diagnosed as
uveitis on his left eye(OS). He had also suffered from leftOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Intraoperative views during PPV. (a) Intraoperative view in PPV showing numerous fibrins (arrow) attached above elevated lesions at the
temporal mid-periphery. (b) Intraoperative view in PPV showing multiple large elevated dome-shaped subretinal yellow-white lesions at the
temporal to inferior mid-peripheral area.
Figure 2 Fundus photograph after PPV. Fundus photograph of the
left eye 2 weeks after PPV. Elevated subretinal yellow-white lesions
have already disappeared, with retinal atrophy remaining at that site.
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corticosteroid pulse therapy based on a suspected diagno-
sis of temporal arteritis. Two weeks later, the vitreous
opacity OS exacerbated, and he was referred to us. He
had no systemic diseases except well-controlled systemic
hypertension and hyperlipidemia.
Best corrected visual acuity (BCVA) was 1.0 on his
right eye(OD) and light perception OS. The right eye
showed a normal appearance. In the left eye, slit lamp
examination showed pigmented keratic precipitates,
Descemet’s membrane folds, and severe cells and flare
with fibrin in the anterior chamber. The fundus was not
visible due to the dense vitreous opacity. B-mode ultra-
sonography showed diffuse high density in the vitreous
cavity and dome-shaped high-density lesions elevated
toward the inside at the site of the temporal peripheral
choroid. Single-flash electroretinography (ERG) results
were normal OD and non-recordable OS. Examination
of serum was normal, including blood counts and liver
function, except for an increase in C-reactive protein
(1.65 mg/dl). In addition, we were informed that chest
computed tomography showed diffuse miliary nodules in
both lungs indicating miliary tuberculosis.
Since these findings suggested infectious endophthal-
mitis, the patient underwent PPV immediately. Intraop-
eratively, the vitreous cavity was filled by dense opacity
with numerous fibrins (Figure 1a). Multiple large,
elevated, dome-shaped subretinal yellow-white lesions
fused to each other were present at the temporal to
inferior mid-periphery (Figure 1b). No retinal break or
retinal detachment was detected. Vitreous gel with fibrin
was removed as much as possible with intravitreal irriga-
tion with balanced salt solution containing ceftazidime
and vancomycin. After the operation, the patient immedi-
ately received triple antituberculous agents orally (isonia-
zid 300 mg/day, ethambutol 750 mg/day, and rifampin
450 mg/day). Later, Mycobacterium tuberculosis wasdetected by bacterial culture from the gastric juices and
vitreous fluids. From these results, the patient was diag-
nosed with tuberculous endophthalmitis.
Two weeks after the operation, the anterior chamber
inflammation decreased to 1+ flare and 2+ cells without
any vitreous opacity. Elevated subretinal yellow-white
lesions regressed with remaining slight retinal degener-
ation at the site corresponding to the area where
subretinal yellow-white lesions had previously existed
(Figure 2). BCVA improved to 0.05 OS. Goldmann
perimetry revealed inferotemporal island scotoma with
central scotoma. ERG results continued to be non-
recordable OS.
Two months after the operation, the patient showed
re-exacerbation of intraocular inflammation OS despite
continuing antituberculous agents. BCVA decreased to
light perception OS. Anterior chamber inflammation
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not be visualized due to diffuse vitreous opacity with
fibrin formation in the anterior vitreous. Although
systemic antibacterial and antifungal drugs were added,
intense intraocular inflammation continued. However,
when oral prednisolone 20 mg/day was initiated, inflam-
mation in the anterior chamber and the vitreous resolved
dramatically, and BCVA improved to 0.15. The oral
prednisolone was gradually decreased and was stopped
11 months after the operation. The antituberculous agents
were also stopped 13 months after the operation. No
recurrence of intraocular inflammation was seen, and the
final visual acuity was 0.1 OS.
Discussion
We encountered this case of tuberculous endophthalmitis
diagnosed by systemic screening and bacterial culture of
vitreous fluids. In the early stage after the operation, we
initiated antituberculous agents, which led to the remis-
sion of endophthalmitis and BCVA improvement.
According to previous reports, the visual prognosis
for tuberculous endophthalmitis is very poor. Of the 13
cases of this disease reported before 2000, 12 eventually
underwent enucleation or evisceration while 1 case
showed spontaneous remission [1,5]. From 2001 on-
ward, three out of five cases underwent enucleation
while endophthalmitis regressed after PPV in the
remaining two cases [1,6]. These observations suggest
that the visual prognosis for this disease is poor despite
the progression of vitrectomy techniques. This disease
often occurs in developing countries that have high-
indigenous rates of tuberculosis. Patients with tubercu-
lar uveitis are likely to be diagnosed with idiopathic
uveitis and are treated solely with local and/or systemic
corticosteroids [7]. In the present case, we speculate
that the systemic corticosteroid therapy that had been
performed at another hospital caused the progression
from choroidal tuberculoma to endophthalmitis. Inves-
tigations of tuberculosis for the eyes and systemic tis-
sues might be also insufficient. Moreover, new diagnostic
tools, such as polymerase chain reaction of M. tuberculosis
using aqueous or vitreous fluids, also have low sensitivity
[7]. Therefore, ophthalmologists should suspect tubercu-
losis routinely as the cause of endophthalmitis and should
perform systemic screening for tuberculosis and analysis of
ocular fluids if necessary. In such cases, the decision of
whether to start empirical antituberculosis treatment in the
absence of positive results is difficult. More sensitive and
rapid tests for ocular tuberculosis are urgently needed to
guide such cases.
In our case, the recurrence of endophthalmitis occurred
2 months after PPV. Inflammation dramatically resolved
with systemic prednisolone therapy, suggesting that thepathological condition was due to an allergic reaction
to M. tuberculosis components and not due to the re-
currence of tubercular infection. This reaction may be
very similar to the Jarisch-Herxheimer reaction, which
is an exacerbated inflammation seen in patients with
tuberculosis just after starting systemic antituberculous
treatment. Therefore, when inflammation recurs or
worsens in patients with ocular tuberculosis, ophthal-
mologists should consider the possibility of an allergic
reaction to the bacterial components.
Conclusions
In conclusion, we encountered a case of tuberculous
endophthalmitis diagnosed by analysis of ocular fluids
obtained by PPV. Triple antituberculous oral agents were
initiated from the early stage after the operation, and
endophthalmitis dramatically disappeared. If endophthal-
mitis is suspected in the patient with systemic tuberculosis
infection, prompt vitrectomy along with the administra-
tion of antituberculous agents may be necessary.
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